EMA grants conditional marketing approval for Paxlovid to treat COVID 19 infection. Pfizer
The treatment consists of a total of 30 pills administered over a five-day period. Two 150-milligram tablets of Paxlovid and one 100-milligram tablet of the drug ritonavir are to be given together to a patient twice daily. A single carton distributed by the company will include all pills required for the full course of treatment. Paxlovid reduces the ability of the SARS-CoV-2 coronavirus to replicate in the body, while ritonavir extends the effectiveness of the Pfizer medication. This enables “it to remain longer in the body at levels that affect the multiplication of the virus".
.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.